BR9507619A - Novos derivados de ácido hidroxímico composições farmacêuticas contendo os mesmos e processo para preparação dos mesmos - Google Patents

Novos derivados de ácido hidroxímico composições farmacêuticas contendo os mesmos e processo para preparação dos mesmos

Info

Publication number
BR9507619A
BR9507619A BR9507619A BR9507619A BR9507619A BR 9507619 A BR9507619 A BR 9507619A BR 9507619 A BR9507619 A BR 9507619A BR 9507619 A BR9507619 A BR 9507619A BR 9507619 A BR9507619 A BR 9507619A
Authority
BR
Brazil
Prior art keywords
group
formula
compounds
pct
preparing
Prior art date
Application number
BR9507619A
Other languages
English (en)
Inventor
Mihaly Barabas
Ede Marvanyos
Laszlo Urogdi
Laszlo Vereczkey
Laszlo Jaszlits
Katalin Biro
Andrea Jednakovits
Erzsebet Radivanyi
Isvanne Udvardy-Nagy
Original Assignee
Biorex Kutato Fejlesztoe Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU9401488A external-priority patent/HU219916B/hu
Application filed by Biorex Kutato Fejlesztoe Kft filed Critical Biorex Kutato Fejlesztoe Kft
Publication of BR9507619A publication Critical patent/BR9507619A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/02Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/18Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9507619A 1994-05-06 1995-05-04 Novos derivados de ácido hidroxímico composições farmacêuticas contendo os mesmos e processo para preparação dos mesmos BR9507619A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9401488A HU219916B (hu) 1989-12-22 1994-05-06 Hidroximsav-származékok, eljárás előállításukra és az azokat tartalmazó gyógyszerkészítmények, valamint egyes intermedierjeik
PCT/HU1995/000014 WO1995030649A1 (en) 1994-05-06 1995-05-04 Novel hydroximic acid derivatives, pharmaceutical compositions containing them and process for preparing same

Publications (1)

Publication Number Publication Date
BR9507619A true BR9507619A (pt) 1997-09-23

Family

ID=10985174

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9507619A BR9507619A (pt) 1994-05-06 1995-05-04 Novos derivados de ácido hidroxímico composições farmacêuticas contendo os mesmos e processo para preparação dos mesmos

Country Status (21)

Country Link
US (1) US5919796A (pt)
EP (1) EP0758315B1 (pt)
JP (1) JP3877762B2 (pt)
KR (1) KR100372312B1 (pt)
CN (1) CN1079789C (pt)
AT (1) ATE170170T1 (pt)
BG (1) BG63336B1 (pt)
BR (1) BR9507619A (pt)
CZ (1) CZ288824B6 (pt)
DE (1) DE69504329T2 (pt)
DK (1) DK0758315T3 (pt)
EE (1) EE03296B1 (pt)
ES (1) ES2123252T3 (pt)
FI (1) FI964436A (pt)
MX (1) MX9605376A (pt)
NO (1) NO307752B1 (pt)
NZ (1) NZ285151A (pt)
PL (1) PL179032B1 (pt)
RO (1) RO115873B1 (pt)
SK (1) SK281387B6 (pt)
WO (1) WO1995030649A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU9502843D0 (en) * 1995-09-29 1995-11-28 Livigene Ltd Pharmaceutical composition
HU222994B1 (hu) 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
UA64716C2 (en) * 1996-08-09 2004-03-15 Pharmaceuticals for therapy or prevention of illnesses connected with dysfunction of vascular endothelial cells
NZ533795A (en) * 2002-01-11 2006-03-31 Biorex Kutato Fejlesztoe Kft Carboxamidine derivatives and their use in the treatment of vascular diseases
BR0302750A (pt) * 2003-08-08 2005-03-29 Catarinense S A Lab Uso de produto compreendendo material vegetal das espécies trichilia sp. associada ou não para a reversão/combate da fibrilação ventricular; composição farmacêutica compreendendo o referido material vegetal para a reversão/combate da fibrilação ventricular; método para a reversão/combate da fibrilação ventricular usando o referido material vegetal; uso do referido material vegetal para a produção de uma composição farmacêutica para a reversão/combate da fibrilação ventricular
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
TW200831479A (en) * 2006-09-26 2008-08-01 Cytrx Corp Pharmaceutical compositions and methods for treating diseases
JP2010511622A (ja) * 2006-12-01 2010-04-15 シトルックス コーポレイション 発作の回復
JP2024500632A (ja) 2020-11-19 2024-01-10 ゼブラ デンマーク エー/エス アリモクロモルクエン酸塩及びその中間体の調製プロセス

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1110460B (it) * 1977-03-02 1985-12-23 Ciba Geigy Ag Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego
JPS608253A (ja) * 1983-06-28 1985-01-17 Showa Denko Kk ヒドロキシイミノブタノン誘導体及び殺虫剤
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
JPH068253A (ja) * 1992-06-29 1994-01-18 Kobe Steel Ltd プラスチック成形品用金型およびその製造方法

Also Published As

Publication number Publication date
JP3877762B2 (ja) 2007-02-07
SK143096A3 (en) 1997-06-04
PL179032B1 (pl) 2000-07-31
EP0758315B1 (en) 1998-08-26
FI964436A (fi) 1996-11-27
BG63336B1 (bg) 2001-10-31
NO964677L (no) 1996-11-05
EE03296B1 (et) 2000-10-16
RO115873B1 (ro) 2000-07-28
ATE170170T1 (de) 1998-09-15
CN1151728A (zh) 1997-06-11
MX9605376A (es) 1998-05-31
PL317154A1 (en) 1997-03-17
EP0758315A1 (en) 1997-02-19
WO1995030649A1 (en) 1995-11-16
CZ325196A3 (en) 1997-06-11
KR100372312B1 (ko) 2003-05-09
ES2123252T3 (es) 1999-01-01
JPH09512815A (ja) 1997-12-22
DE69504329T2 (de) 1999-04-08
SK281387B6 (sk) 2001-03-12
NO307752B1 (no) 2000-05-22
DK0758315T3 (da) 1999-05-25
CN1079789C (zh) 2002-02-27
US5919796A (en) 1999-07-06
NZ285151A (en) 1998-09-24
FI964436A0 (fi) 1996-11-05
CZ288824B6 (cs) 2001-09-12
BG100954A (en) 1997-08-29
DE69504329D1 (de) 1998-10-01
AU2416195A (en) 1995-11-29
AU691284B2 (en) 1998-05-14
KR970702845A (ko) 1997-06-10
NO964677D0 (no) 1996-11-05

Similar Documents

Publication Publication Date Title
YU155290A (sh) Dusikove spojine
KR950704304A (ko) 이환식 헤테로환 함유 술폰아미드 및 술폰산 에스테르 유도체(bicyclic heterocyclic sulfonamide and sulfonic ester derivatives)
KR970000250A (ko) 개선된 항바이러스 화합물
PT958296E (pt) Compostos heterociclicos processo para a sua preparacao composicoes farmaceuticas contendo-os e sua utilizacao no tratamento da diabetes e doencas relacionadas
DE68914292D1 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
BR9507619A (pt) Novos derivados de ácido hidroxímico composições farmacêuticas contendo os mesmos e processo para preparação dos mesmos
ES2100222T3 (es) Derivados del acido aminoalcansulfonico y compuestos farmaceuticos a utilizar para prevenir o tratar afecciones cardiacas.
DE69231422D1 (de) Pyridoncarbonsäurederivate
ATE270279T1 (de) Benzofuroxanderivate und ihre verwendung zur behandlung von angina pectoris
DE69814800T2 (de) Epoxysuccinamid-derivate oder ihre salze
ES2019840A6 (es) Procedimiento para preparar nuevos derivados de tieno-triazolo-diazepina.
EA200000389A3 (ru) Новые замещенные пиридины или пиперидины, способ их получения и содержащие их фармацевтические композиции
ATE244258T1 (de) Halo-derivate von 9-deoxo-9a-aza-9a- homerythromycin a
NO159927C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aromatiske aminoacetylener.
CA2189652A1 (en) Novel hydroximic acid derivatives, pharmaceutical compositions containing them and process for preparing same
IT1246778B (it) Nitrosocarbamoil derivati di acidi gem-difosfonici, un processo per la loro preparazione e composizioni farmaceutiche che li contengono
ES2085540T3 (es) 2-(3-fenilpropil)hidrazinas, productos intermedios en y un procedimiento para la preparacion de las mismas, y su uso como medicamentos.

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
EG Technical examination (opinion): publication of technical examination (opinion)
HJEG Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
HKEG Application refused (deleted)
FG9A Patent or certificate of addition granted
B25G Requested change of headquarter approved
B24C Patent annual fee: request for for restoration

Free format text: REFERENTE A 15A E 16A ANUIDADES

B24H Lapse because of non-payment of annual fees (definitively: art 78 iv lpi)
B24F Patent annual fee: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2257 DE 08/04/2014 POR TER SIDO INDEVIDA.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AS 15A E 16A ANUIDADES.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2606 DE 15-12-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.